The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Limited Alzheimer-Type Neurodegeneration in Experimental Obesity and Type 2 Diabetes Mellitus
Open accessAbstract
Alzheimer's disease (AD) is associated with brain insulin resistance and insulin deficiency, whereas Type 2 diabetes mellitus (T2DM) is associated with peripheral insulin resistance. This study assesses the degree to which T2DM causes AD-type neurodegeneration. In a C57BL/6 mouse model of obesity and T2DM, we characterized the histopathology, gene expression, and insulin and insulin-like growth factor (IGF)-receptor binding in temporal lobe. High fat diet (HFD) feeding for 16 weeks doubled mean body weight, caused T2DM, and marginally reduced mean brain weight. These effects were associated with significantly increased levels of tau, IGF-I receptor, insulin receptor substrate-1 (IRS-1), IRS-4, ubiquitin, glial fibrillary acidic protein, and 4-hydroxynonenol, and decreased expression of beta-actin. HFD feeding also caused brain insulin resistance manifested by reduced BMAX for insulin receptor binding, and modestly increased brain insulin gene expression. However, HFD-fed mouse brains did not exhibit AD histopathology, increases in amyloid-beta or phospho-tau, or impairments in IGF signaling or acetylcholine homeostasis. Obesity and T2DM cause brain atrophy with insulin resistance, oxidative stress, and cytoskeleton degradation, but the absence of many features that typify AD suggests that obesity and T2DM may contribute to, but are not sufficient to cause AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence suggests that insulin resistance, a hallmark of diabetes, develops in Alzheimer’s brains (, 2000; Craft et al., 1999; de la Monte, 2009; Moroz et al., 2008; Pedersen and Flynn, 2004; Razay and Wilcock, 1994; Watson and Craft, 2003).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Moroz et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790
Adipokines: The missing link between insulin resistance and obesity
Antuna-Puente, B., Fève, B., Fellahi, S., & Bastard, J. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.09.004 · Cited by 760
Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · cited 5×
“…A β PP gene expression; 4) pro-inflammatory cytokine activation; 5) impairments in IGF-I and IGF-II receptor binding; 6) reduced expression of IGF-I and IGF-II polypeptide and receptor genes;and 7) impairments in acetylcholine homeostasis [14,32,50,56] were not present in ourmod-el of obesity/T2DM.”
InfluentialIntranasal insulin improves memory in humans
Benedict, C., Hallschmid, M., Hatke, A., Schultes, B., Fehm, H. L., Born, J., & Kern, W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.04.003 · Cited by 699
Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 619
Relation of diabetes to mild cognitive impairment
Luchsinger, J. A., Reitz, C., Patel, B., Tang, M.-X., Manly, J. J., & Mayeux, R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.570 · Cited by 592
de la Monte, S. M., & Wands, J. R. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7106 · Cited by 552
Vascular risk factors, incidence of MCI, and rates of progression to dementia
Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530
Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons
Hong, M., & Lee, V. M. ‐. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 522
Craft, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362137 · Cited by 487
Pathology of Nonalcoholic Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2007) · American Journal of Clinical Pathology · doi:10.1309/rtpm1py6ygbl2g2r · Cited by 469
Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease
Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467
The epidemiology of the dementias: an update
Qiu, C., Ronchi, D. D., & Fratiglioni, L. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32816ebc7b · Cited by 434
Body Mass Index in Midlife and Risk of Alzheimer Disease and Vascular Dementia
Whitmer, R., Gunderson, E., Quesenberry, C., Zhou, J., & Yaffe, K. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362047 · Cited by 430
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426
Martins, I. J., Hone, E., Foster, J. K., Sünram-Lea, S. I., Gnjec, A., Fuller, S. J., Nolan, D., Gandy, S. E., & Martins, R. N. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001854 · Cited by 388
Neurodegenerative disorders associated with diabetes mellitus
Ristow, M. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0552-1 · Cited by 355
Craft, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.021 · Cited by 347
de la Monte, S. M., Tong, M., Lester-Coll, N. H., Plater, M. E., & Wands, J. R. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10113 · Cited by 329
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Pedersen, W. A., McMillan, P. J., Kulstad, J. J., Leverenz, J. B., Craft, S., & Haynatzki, G. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.018 · Cited by 320
Johnstone, M., Gearing, A. J. H., & Miller, K. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00226-4 · Cited by 316
Winocur, G., Greenwood, C. E., Piroli, G. G., Grillo, C. A., Reznikov, L. R., Reagan, L. P., & McEwen, B. S. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.5.1389 · Cited by 292
Role of mitochondria in non‐alcoholic fatty liver disease
Pessayre, D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04640.x · Cited by 287
Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease
Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284
Intranasal Insulin Reduces Body Fat in Men but not in Women
Hallschmid, M., Benedict, C., Schultes, B., Fehm, H.-L., Born, J., & Kern, W. (2004) · Diabetes · doi:10.2337/diabetes.53.11.3024 · Cited by 281 · cited 1×
“In addition, treatment with intranasal insulin [2,3,23,24],and/or insulin sensitizer agents such as peroxisome proliferator activated receptor agonists [14,30,57] which has demonstrated ability to increase memory and cognitive function, may also be beneficial in reducing cognitive dysfunction in…”
Diabetes mellitus and dementia
Pasquier, F., Boulogne, A., Leys, D., & Fontaine, P. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70298-7 · Cited by 278
Studies of the effects of high fat diets on cognitive function in a rat model
Winocur, G., & Greenwood, C. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.003 · Cited by 250
Cardiovascular risk factors and Alzheimer’s disease
Luchsinger, J. A., & Mayeux, R. P. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0056-z · Cited by 246
The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease
Xu, W., Qiu, C., Winblad, B. G., & Fratiglioni, L. (2006) · Diabetes · doi:10.2337/db06-0879 · Cited by 221
Type 2 diabetes and risk of cognitive impairment and dementia
Whitmer, R. A. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0058-7 · Cited by 201
Can Dementia Be Prevented? Brain Aging in a Population-Based Context
Haan, M. N., & Wallace, R. B. (2004) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.25.101802.122951 · Cited by 191
Brain Aging in Very Old Men With Type 2 Diabetes
Korf, E. S. C., White, L. R., Scheltens, P., & Launer, L. J. (2006) · Diabetes Care · doi:10.2337/dc06-0243 · Cited by 190
van Groen, T., Puurunen, K., Mäki, H.-M., Sivenius, J., & Jolkkonen, J. (2005) · Stroke · doi:10.1161/01.str.0000169933.88903.cf · Cited by 185
Rosiglitazone Induces Mitochondrial Biogenesis in Mouse Brain
Strum, J. C., Shehee, R., Virley, D. J., Richardson, J. C., Mattie, M. D., Selley, P., Ghosh, S., Nock, C. M., Saunders, A. M., & Roses, A. D. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11108 · Cited by 183
Intranasal Insulin to Improve Memory Function in Humans
Benedict, C., Hallschmid, M., Schultes, B., Jan Born, A., & Kern, W. (2007) · Neuroendocrinology · doi:10.1159/000106378 · Cited by 171
Craft, S. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213866.86934.7e · Cited by 167
Cognitive impairment in rats fed high-fat diets: A specific effect of saturated fatty-acid intake.
Greenwood, C. E., & Winocur, G. (1996) · Behavioral Neuroscience · doi:10.1037//0735-7044.110.3.451 · Cited by 166
Obese men respond to cognitive but not to catabolic brain insulin signaling
Hallschmid, M., Benedict, C., Schultes, B., Born, J., & Kern, W. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803722 · Cited by 165
Verdelho, A., MADUREIRA, S., Ferro, J. M., Basile, A. M., Chabriat, H., Erkinjuntti, T., Fazekas, F., Hennerici, M. G., O'Brien, J. T., Pantoni, L., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.110361 · Cited by 162
Govind, S., Kozma, R., Monfries, C. A. L., Lim, L., & Ahmed, S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.3.579 · Cited by 162
Clinical aspects of inflammation in Alzheimer's disease
Rosenberg, P. B. (2005) · International Review of Psychiatry · doi:10.1080/02646830500382037 · Cited by 158
Protein quality control in Alzheimer's disease by the ubiquitin proteasome system
de Vrij, F. M. S., Fischer, D. F., VANLEEUWEN, F., & Hol, E. M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.001 · Cited by 155
Role of adipocytokines in obesity-associated insulin resistance
Zou, C., & Shao, J. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.06.006 · Cited by 143
Müller, T., Concannon, C. G., Ward, M. W., Walsh, C. M., Tirniceriu, A., Tribl, F., Kögel, D., Prehn, J. H. M., & Egensperger, R. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-04-0283 · Cited by 141
Marchesini, G., & Marzocchi, R. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.013 · Cited by 139
The Clinical and Biological Relationship between Type II Diabetes Mellitus and Alzheimers Disease
Nicolls, M. R. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480555 · Cited by 131
Update on non-alcoholic fatty liver disease in children
Papandreou, D., Rousso, I., & Mavromichalis, I. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.02.002 · Cited by 126
Diabetic neuropathies in brain are induced by deficiency of BDNF
Nitta, A., Murai, R., Suzuki, N., Ito, H., Nomoto, H., Katoh, G., Furukawa, Y., & Furukawa, S. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00220-9 · Cited by 120
Butterfield, D. A., Gnjec, A., Poon, H. F., Castegna, A., Pierce, W. M. J., Klein, J. B., & Martins, R. N. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10407 · Cited by 120
Gutala, R. V., & Reddy, P. H. (2003) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2003.09.005 · Cited by 118
Watson, G. S., & Craft, S. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.017 · Cited by 111
Therapeutic Use of Agonists of the Nuclear Receptor PPARγ in Alzheimers Disease
Landreth, G. E. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362092 · Cited by 108
Cohen, A. C., Tong, M., Wands, J. R., & de la Monte, S. M. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00450.x · Cited by 102
Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)
Hoyer, S., Lannert, H., Nöldner, M., & Chatterjee, S. S. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050232 · Cited by 102
Soscia, S. J., Tong, M., Xu, X. J., Cohen, A. C., Chu, J., Wands, J. R., & de la Monte, S. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6208-2 · Cited by 100
Weinstock, M., & Shoham, S. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0058-y · Cited by 97
Diabetes and brain aging: Epidemiologic evidence
Launer, L. J. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0069-1 · Cited by 87
Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease
Watson, G. S., Bernhardt, T., Reger, M. A., Cholerton, B., Baker, L. D., Peskind, E. R., Asthana, S., Plymate, S. R., Frölich, L., & Craft, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.11.011 · Cited by 75
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease
ETIENNE, D., Kraft, J., Ganju, N., Gómez‐Isla, T., Gemelli, B., Hyman, B. T., Hedley‐Whyte, E. T., Wands, J. R., & de la Monte, S. M. (1998) · Journal of Alzheimer s Disease · doi:10.3233/jad-1998-1205 · Cited by 73
Postischemic hyperthermia induces Alzheimer-like pathology in the rat brain
Sinigaglia‐Coimbra, R., Cavalheiro, É. A., & Coimbra, C. G. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0487-3 · Cited by 68
Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid β-peptide
Yan, S. D., Roher, A. E., Chaney, M., Zloković, B. V., Schmidt, A. M., & Stern, D. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00041-7 · Cited by 58
Primate-like amyloid-β sequence but no cerebral amyloidosis in aged tree shrews
Pawlik, M., Fuchs, E., Walker, L. C., & Levy, E. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00017-2 · Cited by 55
de la Monte, S. M., Chen, G., Rivera, E. J., & Wands, J. R. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3305-3 · Cited by 46
Nitrergic Neurodegeneration in Cerebral Arteries of Streptozotocin-Induced Diabetic Rats
Cellek, S., Anderson, P. N., & Foxwell, N. (2005) · Diabetes · doi:10.2337/diabetes.54.1.212 · Cited by 26
Brain glutamate dehydrogenase changes in streptozotocin diabetic rats as a function of age
Biju, M. P., & Paulose, C. S. (1998) · IUBMB Life · doi:10.1080/15216549800201002 · Cited by 24
[Risk factors for cognitive impairment].
Cicconetti, P., Riolo, N., Priami, C., Tafaro, L., & Ettore, E. (2004) · PubMed · Cited by 23
Insulin Resistance, Glycemic Control and Adiposity: Key Determinants of Healthy Lifespan
DiStefano, P. S., Curtis, R., & Geddes, B. J. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362038 · Cited by 14
Flagged first, then by citations
Cited by
Sorted by citations
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Obesity and neuroinflammation: A pathway to cognitive impairment
Miller, A. A., & Spencer, S. J. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.04.001 · Cited by 834
Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production
Mehran, A. E., Templeman, N. M., Brigidi, G. S., Lim, G. E., Chu, K.-Y., Hu, X., Botezelli, J. D., Asadi, A., Hoffman, B. G., Kieffer, T. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.019 · Cited by 498
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 472
“Correspondingly, experimental diet-induced obesity and T2DM cause cognitive declines [35] with deficits in spatial learning and memory [120], and brain atrophy with insulin resistance, inflammation, oxidative stress, and cholinergic dysfunction [111, 121].”
BackgroundBrain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
de la Monte, S. M. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 468
“With experimental steatohepatitis caused by DIO or low-level nitrosamine exposure, hepatic and peripheral insulin resistance are also accompanied by locally and peripherally increased ceramide levels [22, 83, 105, 123, 124].”
Background
Metadata
- Authors
- Moroz, N., Tong, M., Longato, L., Xu, H., & de la Monte, S. M.
- Affiliations
- Brown University (US)
- Departments of Medicine, Pathology, and Clinical Neuroscience, Divisions of Gastroenterology and Endocrinology, and the Liver Research Center, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2008-08-26
- Volume
- 15
- Issue
- 1
- Pages
- 29-44
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC10074393
- OpenAlex
- W157753509
- Cited by
- 151
- References
- 71
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 10 · 2023: 2 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 4 · 2018: 9 · 2017: 4 · 2016: 8 · 2015: 9 · 2014: 11 · 2013: 14 · 2012: 17
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Charles H. Hood Foundation
- National Institute for Health and Care Research
- National Institutes of Health (AA-02169, AA02666, AA-11431, 5r01aa011431-26)
- National Institute on Alcohol Abuse and Alcoholism (AA-02666, R01-AA011431, K24 AA016126, AA-12908, AA-02169, AA-16126, AA11431, R56AA011431, R01AA012908, R37AA002666, R37AA011431, R01AA002666)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- Alzheimer's disease, type 2 diabetes
- MeSH terms
- Actins, Aldehydes, Alzheimer Disease, Animals, Atrophy, Brain, Diabetes Mellitus, Type 2, Enzyme-Linked Immunosorbent Assay, Glial Fibrillary Acidic Protein, Insulin Resistance, Insulin-Like Growth Factor I, Mice, Inbred C57BL, Nerve Degeneration, Obesity, RNA, Messenger, Gene Expression, Amyloid beta-Peptides, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Ubiquitin, Adaptor Proteins, Signal Transducing, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
